Overview

Treatment of Depression With Quetiapine

Status:
Terminated
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the mood stabilizing and antipsychotic properties of quetiapine in the treatment of depression by comparing subjects who were randomly assigned to either quetiapine monotherapy, quetiapine and citalopram; or haloperidol and citalopram. We hypothesize that quetiapine monotherapy would have similar effects to the combination of a first generation antipsychotic plus an antidepressant for the treatment of a major depressive episode with psychosis.
Phase:
Phase 3
Details
Lead Sponsor:
Rush University Medical Center
Collaborator:
AstraZeneca
Treatments:
Quetiapine Fumarate